Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 40.00 NOK
Change Today 0.00 / 0.00%
Volume 0.0
As of 10:25 AM 04/20/15 All times are local (Market data is delayed by at least 15 minutes).

medistim asa (MEDI) Snapshot

Open
40.00 NOK
Previous Close
40.00 NOK
Day High
40.00 NOK
Day Low
39.00 NOK
52 Week High
03/12/15 - 60.00 NOK
52 Week Low
09/29/14 - 20.20 NOK
Market Cap
733.5M
Average Volume 10 Days
4.7K
EPS TTM
1.73 NOK
Shares Outstanding
18.3M
EX-Date
04/27/15
P/E TM
23.2x
Dividend
1.40 NOK
Dividend Yield
2.00%
Current Stock Chart for MEDISTIM ASA (MEDI)

Related News

No related news articles were found.

medistim asa (MEDI) Related Businessweek News

No Related Businessweek News Found

medistim asa (MEDI) Details

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the Unites States, Europe, Asia, and the rest of the world. It offers VeriQ, an intraoperative transit time flow measurement (TTFM) and doppler velocity measurements for intraoperative blood flow and graft patency verification; and VeriQ C, a system that combines ultrasound imaging and TTFM in a single system. The company also provides a range of flow probes, such as TTFM probes; Doppler X-Plore probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis; autoclavable QuickFit and Vascular TTFM probes steam; and PeriVascular transit time probes for measuring blood volume flow for the surgical applications, as well as offers cleaning and sterilization services of flow probes. In addition, it offers imaging probes used with the VeriQ C system to provide images for enhancing intraoperative assessment. Further, the company sells electronic stethoscopes; and distributes and sells third party products. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Founded in 1984

medistim asa (MEDI) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: 2.3M NOK
Chief Financial Officer
Total Annual Compensation: 1.1M NOK
Vice President of Development
Total Annual Compensation: 1.0M NOK
Vice President of Production
Total Annual Compensation: 1.1M NOK
Quality Manager
Total Annual Compensation: 680.4K NOK
Compensation as of Fiscal Year 2013.

medistim asa (MEDI) Key Developments

Medi-Stim ASA Recommends Dividend

Medi-Stim ASA announced that the Board will suggest to the General Meeting a dividend of NOK 1.40 per share against NOK 0.80 a year ago. The equals a pay out ratio of 80% against 55% a year ago.

Medi-Stim ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

Medi-Stim ASA reported earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, sales were NOK 66,092,000 against NOK 52,189,000 a year ago. Operating results before depreciation and write offs was NOK 16,548,000 against NOK 11,009,000 a year ago. Operating result was NOK 14,449,000 against NOK 8,983,000 a year ago. Pretax profit was NOK 15,655,000 against NOK 9,710,000 a year ago. Result after tax was NOK 11,057,000 against NOK 7,758,000 a year ago. Earnings per share diluted were NOK 0.61 against 0.43 a year ago. For the full year, sales were NOK 214,817,000 against NOK 190,979,000 a year ago. Operating results before depreciation and write offs was NOK 51,622,000 against NOK 43,309,000 a year ago. Operating result was NOK 43,362,000 against NOK 35,605,000 a year ago. Pretax profit was NOK 44,892,000 against NOK 37,488,000 a year ago. Result after tax was NOK 31,245,000 against NOK 26,536,000 a year ago. Earnings per share diluted were NOK 1.73 against NOK 1.47 a year ago. Cash flow from operation was NOK 47,808,000 against NOK 26,287,000 a year ago. Net interest bearing debt was NOK 31,350,000 against NOK 14,865,000 a year ago.

Medi-Stim ASA, Q4 2014 Earnings Call, Feb 26, 2015

Medi-Stim ASA, Q4 2014 Earnings Call, Feb 26, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MEDI:NO 40.00 NOK 0.00

MEDI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MEDI.
View Industry Companies
 

Industry Analysis

MEDI

Industry Average

Valuation MEDI Industry Range
Price/Earnings 22.6x
Price/Sales 3.3x
Price/Book 5.1x
Price/Cash Flow 18.1x
TEV/Sales 3.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDISTIM ASA, please visit www.medistim.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.